Circulating Levels of IL‐6 Receptor and gp130 and Long‐Term Clinical Outcomes in ST‐Elevation Myocardial Infarction

Circulating Levels of IL‐6 Receptor and gp130 and Long‐Term Clinical Outcomes in ST‐Elevation Myocardial Infarction

BackgroundReports on soluble interleukin‐6 (IL‐6) receptor (sIL‐6R) and glycoprotein 130 (sgp130) in ST‐elevation myocardial infarction (STEMI) are few and include a small number of patients. The aim of this study was to investigate the possible association between levels of these biomarkers in the...

Full description

Bibliographic Details
Main Authors: Vibeke N. Ritschel, Ingebjørg Seljeflot, Harald Arnesen, Sigrun Halvorsen, Jan Eritsland, Morten W. Fagerland, Geir Ø. Andersen
Format: Article
Language:English
Published: Wiley 2016-06-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
inflammation
interleukins
myocardial infarction
prognosis
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.115.003014

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.115.003014

Similar Items